
Opinion|Videos|June 29, 2024
Current Landscape of Biosimilar Use in US Healthcare Space
Dr Humphreys drives a conversation scoping the biosimilar landscape and available treatment options.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Provide an overview of the current landscape of FDA biosimilar approvals. What biosimilars are available? What trends are you seeing?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
AbbVie Joins Trump Drug Pricing Effort, Pledges $100B in US R&D Investment
2
OpenAI for Healthcare Aims to Streamline Clinical Workflows, Reduce Administrative Burden
3
Managed Care Cast News Roundup: January 13, 2026
4
How EHRs Help Identify Diabetes Risk in Families of Adults With Prediabetes
5



























































